Favipiravir induces HuNoV viral mutagenesis and infectivity loss with clinical improvement in immunocompromised patients

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 259(2024) vom: 19. Feb., Seite 109901
Auteur principal: Kreins, Alexandra Y (Auteur)
Autres auteurs: Roux, Emma, Pang, Juanita, Cheng, Iek, Charles, Oscar, Roy, Sunando, Mohammed, Reem, Owens, Stephen, Lowe, David M, Brugha, Rossa, Williams, Rachel, Howley, Evey, Best, Timothy, Davies, E Graham, Worth, Austen, Solas, Caroline, Standing, Joseph F, Goldstein, Richard A, Rocha-Pereira, Joana, Breuer, Judith
Format: Article en ligne
Langue:English
Publié: 2024
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't Favipiravir Human norovirus infection Immunodeficiency Mutagenic antivirals Virus whole-genome-sequencing Zebrafish larvae favipiravir EW5GL2X7E0 plus... Antiviral Agents RNA-Dependent RNA Polymerase EC 2.7.7.48 Amides Pyrazines